Key result
Single ventricle physiology is linked to ~5-fold greater stunting three years post-heart transplant versus cardiomyopathy.
Why the study?
Malnutrition is common in children with single ventricle congenital heart disease, but the impact of heart transplantation on their nutritional status is understudied.
Does heart transplantation improve growth stunting and wasting in children with single ventricle congenital heart disease compared to those with cardiomyopathy?
Cohort (n=86)
No
Does heart transplantation improve growth stunting and wasting in children with single ventricle congenital heart disease compared to those with cardiomyopathy?
Absolute Event Rate: 38% vs 7%
p-value: p=0.01
Longitudinal growth remains impaired for several years after heart transplantation in single ventricle patients compared to cardiomyopathy patients, even when weight gain is achieved.
Stunting persists longer after transplant in single ventricle vs cardiomyopathy patients; leaves open whether targeted interventions can improve growth recovery.
BACKGROUND: Malnutrition is common among children with single ventricle (SV) congenital heart disease (CHD). The impact of heart transplantation (HT) on nutritional status in SV patients is understudied. Our aim was to evaluate anthropometric changes in SV patients after HT, compared with those transplanted for cardiomyopathy (CM). METHODS: We performed a single-center retrospective chart review of SV and CM patients < 18 years who underwent HT from January 01, 2010 to December 05, 2017. Wasting and stunting were defined as z-scores for weight-for-age or height-for-age ≤-2, respectively. Changes in these indices between HT and 3 years post-HT were analyzed. RESULTS: Of 86 eligible patients, 28 (33%) had SV CHD and 58 (67%) had CM. Data were available at 3 years post-HT for 57 patients. At transplant, wasting was equally present in SV versus CM patients (7/28, 25% vs. 9/58, 16%, P = .22), which remained true at 3 years post-HT (2/16, 13% vs. 3/41, 7%, P = .61). At transplant, stunting was more common in SV than CM patients (17/28, 61% vs. 8/58, 14%, P < .001). At 3 years post-HT, 6 of 16 (38%) SV patients and 3 of 41 (7%) CM patients remained stunted (P = .01). Among all patients, wasting decreased from transplant to end-point (19% vs. 9%, P = .05), but stunting did not (29% vs. 16%, P = .2), such that wasting and stunting were associated at transplant (P < .001) but not at end-point (P = .17). CONCLUSIONS: Longitudinal growth remains impaired for several years after HT in SV patients, even when weight gain is achieved, suggesting that some factors contributing to growth impairment persist despite resolution of SV physiology.
No takes yet. Share an insight, caveat, or question.
Power et al. (2019) conducted a cohort in Single ventricle congenital heart disease (n=86). Single ventricle congenital heart disease vs. Cardiomyopathy was evaluated on Stunting (height-for-age z-score ≤-2) at 3 years post-heart transplantation (p=0.01). Following heart transplantation, stunting remained significantly more common at 3 years in patients with single ventricle physiology compared to those with cardiomyopathy (38% vs 7%, P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: